Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Di Chiara

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Minerva Medica|September 1, 1980
[Excessive prolactinemic response to sulpiride in patients with mild essential hypertension. Index of diminished hypothalamic dopaminergic activity]G Paladini, E Sponza, O Geatti, et al.
The Thoracic and Cardiovascular Surgeon|March 29, 2011
Endobronchial valve for secondary pneumothorax in a severe emphysema patientM Schiavon, G Marulli, A Zuin, et al.
Tumori|October 31, 1991
Evaluation of the circulating glycoprotein CA549 in mammary cancer and other malignanciesL Clocchiatti, F De Biasi, G Cartei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitorsL Schirosi, N Nannini, D Nicoli, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Minerva Medica|September 1, 1980
[Excessive prolactinemic response to sulpiride in patients with mild essential hypertension. Index of diminished hypothalamic dopaminergic activity]G Paladini, E Sponza, O Geatti, et al.
The Thoracic and Cardiovascular Surgeon|March 29, 2011
Endobronchial valve for secondary pneumothorax in a severe emphysema patientM Schiavon, G Marulli, A Zuin, et al.
Tumori|October 31, 1991
Evaluation of the circulating glycoprotein CA549 in mammary cancer and other malignanciesL Clocchiatti, F De Biasi, G Cartei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitorsL Schirosi, N Nannini, D Nicoli, et al.
Pageof 1